Price$0.15+0.00 (+0.00%)
2025-08-042025-11-04
Latest news
25 items- SECSEC Form SEC STAFF ACTION filed by Novo Integrated Sciences Inc.SEC STAFF ACTION - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form NT 10-Q filed by Novo Integrated Sciences Inc.NT 10-Q - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form 10-K filed by Novo Integrated Sciences Inc.10-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- PRNovo Integrated Sciences Reports 2024 Fiscal Year Financial ResultsNovo Integrated Sciences, Inc. (OTC:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints providing services and product innovation, today reported its financial results for the fiscal year ended August 31, 2024. Robert Mattacchione, the Company's CEO and Board Chairman, stated, "The Company remains committed to the commercialization of its proprietary product offerings and the expansion and delivery of its essential services and solutions to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and
- SECSEC Form NT 10-K filed by Novo Integrated Sciences Inc.NT 10-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form DEFA14A filed by Novo Integrated Sciences Inc.DEFA14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Other Events8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form DEFA14A filed by Novo Integrated Sciences Inc.DEFA14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update, Other Events8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form DEF 14A filed by Novo Integrated Sciences Inc.DEF 14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form PRE 14A filed by Novo Integrated Sciences Inc.PRE 14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form S-8 filed by Novo Integrated Sciences Inc.S-8 - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- INSIDERSEC Form 4 filed by Chief Operating Officer David Christopher Mehlin4 - Novo Integrated Sciences, Inc. (0001138978) (Issuer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
NVOS FAQ
5 questionsWhat does Novo Integrated Sciences Inc. do?
Novo Integrated Sciences, Inc., together with its subsidiaries, provides primary healthcare services. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive...Where does NVOS stock trade?
Novo Integrated Sciences Inc. (NVOS) is listed on NASDAQ.What sector and industry is NVOS in?
Novo Integrated Sciences Inc. operates in the Industrials sector, Industrial Machinery/Components industry.What companies are similar to NVOS?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), ETN (Eaton Corporation PLC), DE (Deere & Company). Compare NVOS side-by-side with any of them on Quantisnow.How can I track NVOS on Quantisnow?
Quantisnow aggregates Novo Integrated Sciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NVOS to receive live email and push alerts on every new disclosure.